SEC-sourced researchBeta
ICCC
IMMUCELL CORP /DE/
Company comparison ↗
Data passport
- CIK
- 0000811641
- Exchange
- Nasdaq
- Business activity
- — · SIC 2835
- Financial inputs
- 6/6
- Filing date
- Mar 30, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 26,493,169.0000 | Mar 30, 2026 |
| December 2025 | 27,644,174.0000 | Mar 30, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 27,644,174.0000 | -1,040,027.0000 | 2,475,292.0000 | 42,532,447.0000 | 15,476,967.0000 | Mar 30, 2026 |
| December 2024 | 26,493,169.0000 | -2,156,629.0000 | 357,903.0000 | 45,100,477.0000 | 17,582,290.0000 | Mar 30, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $27.64M | December 2025 | Mar 30, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $26.49M | December 2024 | Mar 30, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$1.04M | December 2025 | Mar 30, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $2.48M | December 2025 | Mar 30, 2026 | 10-K |
| Total assetsAssets | $42.53M | December 2025 | Mar 30, 2026 | 10-K |
| Total liabilitiesLiabilities | $15.48M | December 2025 | Mar 30, 2026 | 10-K |